Workflow
智能产业基地项目
icon
Search documents
深圳市卫光生物制品股份有限公司 关于竞得土地使用权并签署成交确认书的公告
Core Viewpoint - The company successfully acquired the land use rights for a plot in Shenzhen for RMB 60.4 million, which aligns with its strategic plan to develop an intelligent industrial base [1][2]. Group 1: Land Acquisition Details - The company participated in the bidding for the land use rights of plot A628-0045, which was publicly announced by the Shenzhen Municipal Government [1]. - The land area is 69,986.43 square meters, with a usage period of 30 years [1]. - The land is categorized under the encouraged industry category for "new drug development and industrialization" as per the "Industrial Structure Adjustment Guidance Catalog (2024)" [1]. Group 2: Purpose and Impact of the Acquisition - The purpose of acquiring the land is to meet the needs of the company's intelligent industrial base project, which is in line with its development strategy and aims for high-quality growth [2]. - The funding for the land acquisition comes from the company's own or self-raised funds, ensuring no adverse impact on its main business or financial stability [2]. - Once the new industrial base is operational, the company plans to relocate its operations and will cooperate with local government authorities to vacate the current facility [2].